'KLOTHO NEUROSCIENCE TO up LONGEVITY, HEALTHY LIFE SPAN, REPLACE SILENCED GENE'

Klotho Neurosciences (NASDAQ: KLTO) has announced breakthrough findings in longevity research centered on the Klotho gene. The company has secured exclusive worldwide licenses for s-KL protein technology, building on Professor Makoto Kuro-O's 1997 discovery linking Klotho blood levels to mammalian lifespan. Recent studies published in Molecular Therapy demonstrated that genetic overexpression of Klotho increased mouse lifespan by 30-40%, while the secreted form (s-KL) showed a 20% lifespan increase. The research revealed s-KL's potential in addressing age-related conditions including cognitive decline, neuroinflammation, sarcopenia, and osteoporosis. KLTO plans to develop s-KL treatments focusing on neurodegenerative diseases like ALS, Alzheimer's, and Parkinson's, supported by patents in the USA, Europe, and China.

https://www.stocktitan.net/news/KLTO/klotho-neuroscience-inc-announces-an-approach-to-increase-longevity-wkjhqbcj4pvw.html